{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:02:56Z","timestamp":1785164576737,"version":"3.55.0"},"reference-count":85,"publisher":"The Endocrine Society","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inequities in diabetes diagnosis, management, and outcomes are deeply rooted in social determinants of health and structural racism. Historical policies such as redlining and concentrated poverty in low-income neighborhoods have shaped environments characterized by limited access to healthy food and proper healthcare, which ultimately led to a disproportionate burden of diabetes in these populations. The consequences of these disparities for racial and ethnic minoritized groups include a lower ability to achieve glycemic targets, receive novel glucose-lowering agents, and\/or have access to diabetes technology. The downstream effect is that this population experiences worse health outcomes from complications (ie, amputation, blindness, end-stage renal disease) and mortality. This narrative review synthesizes current literature on racial\/ethnic inequities in diabetes care, highlighting differences in screening, glycemic control, complication rates, and mortality in people living with diabetes from diverse racial and ethnic backgrounds, but also identifies opportunities for intervention to ensure equitable access to evidence-based care.<\/jats:p>","DOI":"10.1210\/clinem\/dgag277","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:46:58Z","timestamp":1784116018000},"source":"Crossref","is-referenced-by-count":0,"title":["Racial\/ethnic inequities in diabetes mellitus: a narrative review"],"prefix":"10.1210","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0944-4625","authenticated-orcid":false,"given":"Tawana","family":"Mazhude","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Montefiore Einstein , Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3093-6147","authenticated-orcid":false,"given":"Raul","family":"Lopez Fanas","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Montefiore Einstein , Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9973-6653","authenticated-orcid":false,"given":"Alyson K","family":"Myers","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Montefiore Einstein , Bronx, NY 10461 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"2026072710535731500_dgag277-B1"},{"issue":"4","key":"2026072710535731500_dgag277-B2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2337\/dc24-2259","article-title":"The burden of diabetes mortality by county, race, and ethnicity in the U.S., 2000\u20132019","volume":"48","author":"Nassereldine","year":"2025","journal-title":"Diabetes Care"},{"issue":"9","key":"2026072710535731500_dgag277-B3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/jama.2022.13885","article-title":"Association of race and ethnicity with prescription of SGLT2 inhibitors and GLP1 receptor agonists among patients with type 2 diabetes in the Veterans Health Administration System","volume":"328","author":"Lamprea-Montealegre","year":"2022","journal-title":"JAMA"},{"issue":"8","key":"2026072710535731500_dgag277-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2021.9883","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999\u20132018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"issue":"10397","key":"2026072710535731500_dgag277-B5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(23)00909-1","article-title":"The role of structural racism and geographical inequity in diabetes outcomes","volume":"402","author":"Agarwal","year":"2023","journal-title":"Lancet"},{"issue":"9","key":"2026072710535731500_dgag277-B6","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2337\/dci23-0001","article-title":"Overview of social determinants of health in the development of diabetes","volume":"46","author":"Hill-Briggs","year":"2023","journal-title":"Diabetes Care"},{"issue":"24","key":"2026072710535731500_dgag277-B7","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2021.06.020","article-title":"Cardiovascular impact of race and ethnicity in patients with diabetes and obesity: JACC focus seminar 2\/9","volume":"78","author":"Joseph","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"Supplement_1","key":"2026072710535731500_dgag277-B8","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc26-S002","article-title":"Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes*","year":"2026","journal-title":"Diabetes Care"},{"issue":"8","key":"2026072710535731500_dgag277-B9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.7326\/M24-0161","article-title":"Body mass index thresholds for Asians: a race correction in need of correction?","volume":"177","author":"Bajaj","year":"2024","journal-title":"Ann Intern Med"},{"issue":"7","key":"2026072710535731500_dgag277-B10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2213-8587(21)00088-7","article-title":"Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study","volume":"9","author":"Caleyachetty","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072710535731500_dgag277-B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2025.06.012","article-title":"Obesity, abdominal obesity, and adipose tissue depots in South Asians with specific reference to Asian Indians: implications of new obesity guidelines","author":"Misra","journal-title":"J Clin Lipidol"},{"issue":"9403","key":"2026072710535731500_dgag277-B12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"issue":"11","key":"2026072710535731500_dgag277-B13","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.2337\/dc25-0556","article-title":"Undiagnosed G6PD deficiency in black and Asian individuals is prevalent and contributes to health inequalities in type 2 diabetes diagnosis and complications","volume":"48","author":"Martin","year":"2025","journal-title":"Diabetes Care"},{"issue":"Supplement_1","key":"2026072710535731500_dgag277-B14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc26-SINT","article-title":"1. Introduction and methodology: standards of care in diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee","year":"2026","journal-title":"Diabetes Care"},{"key":"2026072710535731500_dgag277-B15","volume-title":"Diabetes in America","author":"Hwang","year":"2025"},{"issue":"12","key":"2026072710535731500_dgag277-B16","doi-asserted-by":"crossref","first-page":"e2138438","DOI":"10.1001\/jamanetworkopen.2021.38438","article-title":"Association between area-level socioeconomic deprivation and diabetes care quality in US primary care practices","volume":"4","author":"Kurani","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10","key":"2026072710535731500_dgag277-B17","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1001\/jamainternmed.2019.2396","article-title":"Evaluation of the cascade of diabetes care in the United States, 2005\u20132016","volume":"179","author":"Kazemian","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2026072710535731500_dgag277-B18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1476-072X-11-48","article-title":"Medication deserts: survey of neighborhood disparities in availability of prescription medications","volume":"11","author":"Amstislavski","year":"2012","journal-title":"Int J Health Geogr"},{"issue":"1","key":"2026072710535731500_dgag277-B19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pcd.2020.01.010","article-title":"Diabetes control in Asian Americans\u2014disparities and the role of acculturation","volume":"15","author":"Yoshida","year":"2021","journal-title":"Prim Care Diabetes"},{"issue":"8","key":"2026072710535731500_dgag277-B20","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.2337\/dc13-2939","article-title":"Prevalence of diabetes among Hispanics\/Latinos from diverse backgrounds: the Hispanic Community Health Study\/Study of Latinos (HCHS\/SOL)","volume":"37","author":"Schneiderman","year":"2014","journal-title":"Diabetes Care"},{"issue":"10","key":"2026072710535731500_dgag277-B21","doi-asserted-by":"crossref","first-page":"e2336307","DOI":"10.1001\/jamanetworkopen.2023.36307","article-title":"Racial and ethnic disparities in glycemic control among insured US adults","volume":"6","author":"Zakaria","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"10","key":"2026072710535731500_dgag277-B22","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/dom.13805","article-title":"Do GLP-1RAs and SGLT-2is reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta-analysis","volume":"21","author":"Mishriky","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"2026072710535731500_dgag277-B23","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.2337\/dc19-2419","article-title":"Efficacy of modern diabetes treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian patients with diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"43","author":"Gan","year":"2020","journal-title":"Diabetes Care"},{"issue":"5","key":"2026072710535731500_dgag277-B24","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2337\/dc20-3007","article-title":"Meta-analyses of results from randomized outcome trials comparing cardiovascular effects of SGLT2is and GLP-1RAs in Asian versus white patients with and without type 2 diabetes","volume":"44","author":"Lee","year":"2021","journal-title":"Diabetes Care"},{"issue":"3","key":"2026072710535731500_dgag277-B25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.21037\/cdt-20-984","article-title":"Factors affecting the efficacy of SGLT2is on heart failure events: a meta-analysis based on cardiovascular outcome trials","volume":"11","author":"Qiu","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"key":"2026072710535731500_dgag277-B26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.diabres.2018.06.009","article-title":"Cardiovascular safety of GLP-1 receptor agonists for diabetes patients with high cardiovascular risk: a meta-analysis of cardiovascular outcomes trials","volume":"143","author":"Wang","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"2026072710535731500_dgag277-B27","first-page":"100111","article-title":"Racial\/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study","volume":"6","author":"Elhussein","year":"2022","journal-title":"Lancet Reg Health Am"},{"issue":"2","key":"2026072710535731500_dgag277-B28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/dom.14894","article-title":"Changes in racial and ethnic disparities in glucose-lowering drug utilization and glycated haemoglobin A1c in US adults with diabetes: 2005-2018","volume":"25","author":"Li","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2026072710535731500_dgag277-B29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/dc22-0383","article-title":"Deficits and disparities in early uptake of glucagon-like peptide 1 receptor agonists and SGLT2i among Medicare-insured adults following a new diagnosis of cardiovascular disease or heart failure","volume":"46","author":"Cromer","year":"2023","journal-title":"Diabetes Care"},{"issue":"15","key":"2026072710535731500_dgag277-B30","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1007\/s11606-024-08961-x","article-title":"Disparities in use of novel diabetes medications by insurance: a nationally representative cohort study","volume":"39","author":"Bepo","year":"2024","journal-title":"J Gen Intern Med"},{"issue":"6","key":"2026072710535731500_dgag277-B31","doi-asserted-by":"crossref","first-page":"808","DOI":"10.7326\/ANNALS-24-01449","article-title":"Availability of cardioprotective medications for type 2 diabetes in the Medicaid program","volume":"178","author":"Makam","year":"2025","journal-title":"Ann Intern Med"},{"issue":"6","key":"2026072710535731500_dgag277-B32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11606-017-4282-9","article-title":"Predictors of insulin initiation in patients with type 2 diabetes: an analysis of the look AHEAD randomized trial","volume":"33","author":"Pilla","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"12","key":"2026072710535731500_dgag277-B33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.47656","article-title":"Trends and disparities in glycemic control and severe hyperglycemia among US adults with diabetes using insulin, 1988-2020","volume":"5","author":"Venkatraman","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2026072710535731500_dgag277-B34","doi-asserted-by":"crossref","first-page":"2444002","DOI":"10.1080\/29944694.2024.2444002","article-title":"Race and ethnic disparities in insulin pump and continuous glucose monitor use between 2017 and 2024: a systematic review with a focus on health equity","volume":"2","author":"Underwood","year":"2025","journal-title":"J Health Equity"},{"issue":"Supplement_1","key":"2026072710535731500_dgag277-B35","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.2337\/dc26-S007","article-title":"Diabetes Technology: Standards of Care in Diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes*","year":"2026","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"2026072710535731500_dgag277-B36","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc26-SINT","article-title":"Introduction and methodology: standards of care in diabetes-2026","volume":"49","author":"American Diabetes Association","year":"2026","journal-title":"Diabetes Care"},{"issue":"6","key":"2026072710535731500_dgag277-B37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.eprac.2021.04.008","article-title":"American association of clinical endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus","volume":"27","author":"Grunberger","year":"2021","journal-title":"Endocr Pract"},{"issue":"8","key":"2026072710535731500_dgag277-B38","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1111\/pedi.13451","article-title":"ISPAD clinical practice consensus guidelines 2022: diabetes technologies: glucose monitoring","volume":"23","author":"Tauschmann","year":"2022","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"2026072710535731500_dgag277-B39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11892-022-01470-3","article-title":"The use of diabetes technology to address inequity in health outcomes: limitations and opportunities","volume":"22","author":"Agarwal","year":"2022","journal-title":"Curr Diab Rep"},{"issue":"4","key":"2026072710535731500_dgag277-B40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/dia.2020.0338","article-title":"Racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes","volume":"23","author":"Agarwal","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2026072710535731500_dgag277-B41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2337\/dc22-1055","article-title":"Racial disparities in access and use of diabetes technology among adult patients with type 1 diabetes in a U.S. Academic Medical Center","volume":"46","author":"Kanbour","year":"2023","journal-title":"Diabetes Care"},{"issue":"5","key":"2026072710535731500_dgag277-B42","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1177\/1932296821995810","article-title":"Racial disparities in diabetes technology use and outcomes in type 1 diabetes in a safety-net hospital","volume":"15","author":"Fantasia","year":"2021","journal-title":"J Diabetes Sci Technol"},{"issue":"11","key":"2026072710535731500_dgag277-B43","doi-asserted-by":"crossref","first-page":"e2445316","DOI":"10.1001\/jamanetworkopen.2024.45316","article-title":"Disparities in continuous glucose monitoring among patients receiving care in federally qualified health centers","volume":"7","author":"Wallia","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2026072710535731500_dgag277-B44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/dia.2022.0340","article-title":"A longitudinal view of disparities in insulin pump use among youth with type 1 diabetes: the SEARCH for diabetes in youth study","volume":"25","author":"Everett","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"2026072710535731500_dgag277-B45","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.2337\/dci22-0018","article-title":"Automated insulin delivery: benefits, challenges, and recommendations. A consensus report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association","volume":"45","author":"Sherr","year":"2022","journal-title":"Diabetes Care"},{"issue":"1","key":"2026072710535731500_dgag277-B46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MED.0000000000000840","article-title":"Addressing disparities in technology use among patients with type 1 diabetes: a review","volume":"31","author":"Kanbour","year":"2024","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"12","key":"2026072710535731500_dgag277-B47","doi-asserted-by":"crossref","first-page":"436","DOI":"10.31083\/j.rcm2512436","article-title":"Diabetes mellitus and cardiovascular disease: exploring epidemiology, pathophysiology, and treatment strategies","volume":"25","author":"Siam","year":"2024","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"2026072710535731500_dgag277-B48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2337\/dci24-0022","article-title":"Trends and inequalities in diabetes-related complications among U.S. Adults, 2000\u20132020","volume":"48","author":"Saelee","year":"2025","journal-title":"Diabetes Care"},{"issue":"1","key":"2026072710535731500_dgag277-B49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/2013.jamainternmed.857","article-title":"Racial differences in the impact of elevated systolic blood pressure on stroke risk","volume":"173","author":"Howard","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"Supplement_1","key":"2026072710535731500_dgag277-B50","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.2337\/dc26-S010","article-title":"Cardiovascular disease and risk management: standards of care in diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes*","year":"2026","journal-title":"Diabetes Care"},{"issue":"3","key":"2026072710535731500_dgag277-B51","doi-asserted-by":"crossref","first-page":"e3683","DOI":"10.1002\/dmrr.3683","article-title":"Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: a systematic review","volume":"40","author":"Chuter","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"2026072710535731500_dgag277-B52","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIR.0000000000001153","article-title":"Health disparities in peripheral artery disease: a scientific statement from the American Heart Association","volume":"148","author":"Allison","year":"2023","journal-title":"Circulation"},{"issue":"4","key":"2026072710535731500_dgag277-B53","doi-asserted-by":"crossref","first-page":"e228399","DOI":"10.1001\/jamanetworkopen.2022.8399","article-title":"Association of race, ethnicity, and rurality with major leg amputation or death among Medicare beneficiaries hospitalized with diabetic foot ulcers","volume":"5","author":"Brennan","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2026072710535731500_dgag277-B54","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2023.10578","article-title":"Diabetic foot ulcers: a review","volume":"330","author":"Armstrong","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"2026072710535731500_dgag277-B55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13047-020-00383-2","article-title":"Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer","volume":"13","author":"Armstrong","year":"2020","journal-title":"J Foot Ankle Res"},{"issue":"10","key":"2026072710535731500_dgag277-B56","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.2337\/dc21-2693","article-title":"Racial disparities in health care with timing to amputation following diabetic foot ulcer","volume":"45","author":"Miller","year":"2022","journal-title":"Diabetes Care"},{"issue":"8","key":"2026072710535731500_dgag277-B57","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamaophthalmol.2023.2289","article-title":"Prevalence of diabetic retinopathy in the US in 2021","volume":"141","author":"Lundeen","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"2026072710535731500_dgag277-B58","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ajo.2025.11.012","article-title":"Racial and ethnic disparities in risk for adverse ocular events in patients with diabetic retinopathy","volume":"282","author":"Anozie","year":"2026","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2026072710535731500_dgag277-B59","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1167\/iovs.06-0934","article-title":"Knowledge, attitudes, and beliefs about dilated eye examinations among African-Americans","volume":"48","author":"Ellish","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"2026072710535731500_dgag277-B60","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.ophtha.2006.04.018","article-title":"Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study","volume":"113","author":"Paz","year":"2006","journal-title":"Ophthalmology"},{"issue":"1","key":"2026072710535731500_dgag277-B61","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2337\/dc13-1507","article-title":"Barriers to eye care among people aged 40 years and older with diagnosed diabetes, 2006\u20132010","volume":"37","author":"Chou","year":"2014","journal-title":"Diabetes Care"},{"issue":"4","key":"2026072710535731500_dgag277-B62","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/08820538.2016.1154170","article-title":"Disparities in adherence to screening guidelines for diabetic retinopathy in the United States: a comprehensive review and guide for future directions","volume":"31","author":"Fathy","year":"2016","journal-title":"Semin Ophthalmol"},{"issue":"5","key":"2026072710535731500_dgag277-B63","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11606-010-1594-4","article-title":"Trends in quality of care and barriers to improvement in the Indian health service","volume":"26","author":"Sequist","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"4","key":"2026072710535731500_dgag277-B64","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamaophthalmol.2022.0052","article-title":"Trends in prevalence and treatment of diabetic macular edema and vision-threatening diabetic retinopathy among Medicare part B fee-for-service beneficiaries","volume":"140","author":"Lundeen","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"19","key":"2026072710535731500_dgag277-B65","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1001\/jama.287.19.2519","article-title":"Ethnic disparities in diabetic complications in an insured population","volume":"287","author":"Karter","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"2026072710535731500_dgag277-B66","doi-asserted-by":"publisher","first-page":"e001847","DOI":"10.1136\/bmjdrc-2020-001847","article-title":"Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes","volume":"9","author":"An","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026072710535731500_dgag277-B67","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101197","article-title":"Evaluating the impact and rationale of race-specific estimations of kidney function: estimations from US NHANES, 2015\u20132018","volume":"42","author":"Tsai","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2026072710535731500_dgag277-B68","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1089\/heq.2023.0095","article-title":"Promoting anti-racism in clinical practice: lessons learned in the process of removing the race coefficient from the estimated glomerular filtration rate algorithm","volume":"7","author":"Boutin-Foster","year":"2023","journal-title":"Health Equity"},{"issue":"2","key":"2026072710535731500_dgag277-B69","doi-asserted-by":"crossref","first-page":"e220460","DOI":"10.1001\/jamanetworkopen.2022.0460","article-title":"Updated US prevalence estimates for chronic kidney disease stage and complications using the new race-free equation to estimate glomerular filtration rate","volume":"5","author":"Walther","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"2026072710535731500_dgag277-B70","doi-asserted-by":"crossref","first-page":"e2418808","DOI":"10.1001\/jamanetworkopen.2024.18808","article-title":"Concordance with screening and treatment guidelines for chronic kidney disease in type 2 diabetes","volume":"7","author":"Edmonston","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2026072710535731500_dgag277-B71","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12882-025-04235-8","article-title":"Ethnic differences in CKD progression among people with type 2 diabetes and rapid eGFR decline: a secondary data analysis","volume":"26","author":"Alobaid","year":"2025","journal-title":"BMC Nephrol"},{"issue":"6","key":"2026072710535731500_dgag277-B72","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2215\/CJN.11871017","article-title":"Incidence and progression of chronic kidney disease in black and white individuals with type 2 diabetes","volume":"13","author":"Gerber","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"2026072710535731500_dgag277-B73","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.2337\/dc20-1258","article-title":"An update on the incidence and burden of diabetic ketoacidosis in the US","volume":"43","author":"Ramphul","year":"2020","journal-title":"Diabetes Care"},{"issue":"7","key":"2026072710535731500_dgag277-B74","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S2213-8587(23)00129-8","article-title":"Disparities in diabetes prevalence and management by race and ethnicity in the USA: defining a path forward","volume":"11","author":"Hassan","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026072710535731500_dgag277-B75","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/dci20-0053","article-title":"Social determinants of health and diabetes: a scientific review","volume":"44","author":"Hill-Briggs","year":"2020","journal-title":"Diabetes care"},{"issue":"7","key":"2026072710535731500_dgag277-B76","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s11606-019-04894-y","article-title":"Randomized trial of a lifestyle intervention for urban low-income African Americans with type 2 diabetes","volume":"34","author":"Lynch","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"3","key":"2026072710535731500_dgag277-B77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0145721709333270","article-title":"A randomized trial of a church-based diabetes self-management program for African Americans with type 2 diabetes","volume":"35","author":"Samuel-Hodge","year":"2009","journal-title":"Diabetes Educ"},{"issue":"4","key":"2026072710535731500_dgag277-B78","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1177\/0145721707304080","article-title":"Promotora diabetes intervention for Mexican Americans","volume":"33","author":"Lujan","year":"2007","journal-title":"Diabetes Educ"},{"issue":"Supplement_1","key":"2026072710535731500_dgag277-B79","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.2337\/dc26-S004","article-title":"Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes*","year":"2026","journal-title":"Diabetes Care"},{"issue":"Supplement_1","key":"2026072710535731500_dgag277-B80","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc26-S001","article-title":"Improving care and promoting health in populations: standards of care in diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes*","year":"2026","journal-title":"Diabetes Care"},{"issue":"1","key":"2026072710535731500_dgag277-B81","doi-asserted-by":"crossref","first-page":"e2144967","DOI":"10.1001\/jamanetworkopen.2021.44967","article-title":"Examination of stigmatizing language in the electronic health record","volume":"5","author":"Himmelstein","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"12","key":"2026072710535731500_dgag277-B82","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1681\/ASN.2022080890","article-title":"Designing interventions addressing structural racism to reduce kidney health disparities: a report from a National Institute of Diabetes and Digestive and Kidney Diseases Workshop","volume":"33","author":"Crews","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2026072710535731500_dgag277-B83","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1353\/hpu.0.0012","article-title":"Diabetes management: utilizing community health workers in a Hawaiian\/Samoan population","volume":"19","author":"Beckham","year":"2008","journal-title":"J Health Care Poor Underserved"},{"issue":"12","key":"2026072710535731500_dgag277-B84","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamainternmed.2025.5420","article-title":"Voucher for healthy foods and diabetes control: a randomized clinical trial","volume":"185","author":"Persaud","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2026072710535731500_dgag277-B85","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev-publhealth-093019-010011","article-title":"Advancing diabetes prevention and control in American Indians and Alaska natives","volume":"43","author":"Lucero","year":"2022","journal-title":"Annu Rev Public Health"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag277\/69019128\/dgag277.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag277\/69019128\/dgag277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:54:10Z","timestamp":1785164050000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article\/doi\/10.1210\/clinem\/dgag277\/8735763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":85,"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag277","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"dgag277"}}